Categories Cancer

Roche nabs breakthrough tag for TIGIT cancer immunotherapy

Roche nabs breakthrough tag for TIGIT cancer immunotherapy Roche’s closely-watched combination of two checkpoint inhibitors – TIGIT-targeting tiragolumab and PD-L1 drug Tecentriq – has claimed breakthrough status from the FDA. Like PD-L1, TIGIT is thought to act as a molecular brake that stops T cells from attacking tumours, and tiragolumab is currently leading the pack […]

Read More
Categories Uncategorized

2 Undervalued Stocks for 2021

2 Undervalued Stocks for 2021 The share price of Johnson & Johnson (NYSE:JNJ) is up a modest 7% over the past year, but 2021 looks like it might be an even better year for the pharmaceutical giant. You can say the same for Pfizer (NYSE:PFE), whose shares are down 0.7% over the past 12 months. […]

Read More